arrow
M

Meera Sridharan

Mayo Clinic
H指数:22
被引数:1,367

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mortality Prediction in Immune TTP Remains Challenging Despite AI Advances

尽管人工智能取得进展,免疫性TTP的死亡率预测仍具挑战性

2026-08-110
OAAI
Thirty Years of Classical Hematology Drugs in the US: Approvals, Costs, and Sales

三十年美国经典血液学药物:批准、成本与销售

2026-03-280
OAAI
Assessment of Classical Hematologists and Classical Hematology Fellowship Programs at NCI-Designated Cancer Centers

NCI指定癌症中心中古典血液学家及古典血液学培训项目的评估

2025-08-140
OAAI
Clinical Outcomes and Treatment Strategies of Adult Transplant-Associated Thrombotic Microangiopathy: External Validation of Harmonizing Definitions and High-Risk Criteria

成人移植相关性血栓性微血管病变的临床结局与治疗策略:定义和危险因素标准的调和及其外部验证

2025-03-060
OA
The clinical impact of acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia: an underrecognized source of major bleeding events

继发于waldenstr ö m巨球蛋白血症的获得性血管性血友病综合征的临床影响: 主要出血事件的一个未被充分认识的来源

LEUKEMIA
IF13.4
2024-08-280
PRE
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura

一种预测免疫介导的血栓性血小板减少性紫癜死亡率的机器学习方法

2024-03-011
OAAI
A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry

USTMA TTP注册表中免疫性血栓性血小板减少性紫癜的致命结果的描述性分析

2024-01-262
OAAI